Tag: CORO
COVID-19 Vaccination Greatly Reduced Morbidity, Mortality Burden in U.S.
Vaccination estimated to have prevented 52, 56, and 58 percent of expected infections, hospitalizations, deaths in adults from Sept. 1 to 30, 2021
Severe COVID-19 Rates Low With Monoclonal Antibody Therapy During Delta Surge
Rates of severe disease low for high-risk patients with mild-to-moderate COVID-19 treated with antispike monoclonal antibodies
Maternal Mortality Up by One-Third During the Pandemic
Increases were highest for Hispanic and non-Hispanic Black women
Prevalence of COVID-19-Related Croup Up During Omicron
Odds of hospitalization not significantly different during periods with alpha or other variant predominance, delta predominance, versus omicron-predominant periods
Provider Availability Linked to COVID-19 Vaccine Uptake in Children
Vaccination coverage for children aged 5 to 11 higher in counties with at least one active COVID-19 vaccine provider versus no provider
Vaccination Protects Overweight, Obese Against Severe COVID-19
Protection against severe COVID-19 similar for those with overweight, obesity versus healthy weight; lower protection seen for underweight
New York City First to Offer Paxlovid at COVID-19 Testing Sites
'Test-to-Treat' program is part of federal and city efforts to catch and treat infections early and be ready for new waves of the pandemic
FDA Tells Vaccine Makers to Update Boosters to Target Omicron Subvariants
Pfizer and Moderna are expected to start producing reformulated doses this summer
Fauci Has ‘Rebound’ COVID After Paxlovid Treatment
However, director of the NIAID says drug kept him out of the hospital
U.S. Orders 105 Million More Pfizer Shots for Fall Booster Campaign
Both Pfizer and Moderna have reported positive results with updated vaccines that target the omicron variant
